private placement finalised

Tissue Therapies Limited ABN 45 101 955 088
Announcement

Biomedical company, Tissue Therapies Limited (ASX: TIS) is very pleased to announce that a new
strategic investor has joined the Company’s share register via a private placement.
The Board of Tissue Therapies has approved a placement of 3 million Fully-paid Ordinary Shares to
this investor at AU$0:37 each, totalling AU$1,110,000, as detailed in the Appendix 3B released to the
ASX following this announcement. The new investment will represent approximately 1.7% of the
Company’s issued capital.